Urology News and Research

Latest Urology News and Research

Endo Pharmaceuticals signs agreement to acquire HealthTronics

Endo Pharmaceuticals signs agreement to acquire HealthTronics

C. R. Bard reaches definitive agreement to acquire SenoRx

C. R. Bard reaches definitive agreement to acquire SenoRx

United BioSource Corporation acquires Abt Bio-Pharma Solutions

United BioSource Corporation acquires Abt Bio-Pharma Solutions

Research analyzes clinical connection of NPH to AD

Research analyzes clinical connection of NPH to AD

Myriad Genetics' third-quarter fiscal 2010 revenues increase 5% to $90.8M

Myriad Genetics' third-quarter fiscal 2010 revenues increase 5% to $90.8M

Celldex reports net loss of $6.6 million for first-quarter 2010

Celldex reports net loss of $6.6 million for first-quarter 2010

Theragenics reports highest quarterly consolidated revenue of $20.3 million

Theragenics reports highest quarterly consolidated revenue of $20.3 million

CA-BSI can be reduced in children through quality improvement efforts: Study

CA-BSI can be reduced in children through quality improvement efforts: Study

BioSante Pharmaceuticals reinitiates GVAX Prostate Cancer Vaccine development

BioSante Pharmaceuticals reinitiates GVAX Prostate Cancer Vaccine development

Investment report on Spectrum Pharmaceuticals

Investment report on Spectrum Pharmaceuticals

Researchers explore use of nanomedicine techniques for treatment of diseases in children

Researchers explore use of nanomedicine techniques for treatment of diseases in children

Watson Pharmaceuticals sued in connection with filing ANDA for generic equivalent of Trilipix

Watson Pharmaceuticals sued in connection with filing ANDA for generic equivalent of Trilipix

Majority of patients who appear healthy may be at risk for cardiovascular disease

Majority of patients who appear healthy may be at risk for cardiovascular disease

FDA approves continuation of Phase IIb clinical trial for superficial bladder cancer

FDA approves continuation of Phase IIb clinical trial for superficial bladder cancer

Pelvic Floor Institute launched to enhance physician knowledge on reconstruction procedures, techniques

Pelvic Floor Institute launched to enhance physician knowledge on reconstruction procedures, techniques

Endo Pharmaceuticals reports 9% increase in first-quarter 2010 revenues

Endo Pharmaceuticals reports 9% increase in first-quarter 2010 revenues

CTCA installs Calypso's real-time tumor tracking technology at Southwestern Regional Medical Center

CTCA installs Calypso's real-time tumor tracking technology at Southwestern Regional Medical Center

Lucile Packard Children's Hospital opens new Center for Fetal Health

Lucile Packard Children's Hospital opens new Center for Fetal Health

A major research initiative to optimize quality of life for cancer survivors

A major research initiative to optimize quality of life for cancer survivors

Kissei to commercialize Protox's PRX302 PSA-activated pro-drug for BPH, prostate cancer in Japan

Kissei to commercialize Protox's PRX302 PSA-activated pro-drug for BPH, prostate cancer in Japan

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.